Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses

CORC > 厦门大学 > 生命科学－已发表论文

	Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses
	Zheng, Q. B. ; Xia, L. ; Wu, W. L. ; Zheng, Z. H. ; Huo, Y. T. ; Wu, J. ; Liu, Y. N. ; Yu, H. ; Chen, Y. X. ; Lau, S. Y. ; Chen, H. L. ; Luo, W. X. ; Xia, N. S. ; Chen YX(陈奕欣)
刊名	http://dx.doi.org/10.1128/AAC.01436-10
	2011-04
关键词	OSELTAMIVIR-RESISTANT INFLUENZA A VIRUS INFECTION TRANSMISSION EPITOPE CHINA ASIA
英文摘要	Science and Technology Foundation of Fujian Province [2009YZ0002]; National Natural Science Foundation of China [30901077]; Ministry of Health [2008ZX10004-006]; University Grants Committee [AoE/M-12/06]; National Institutes of Health [HHSN2662007 00005C]; Highly pathogenic H5N1 virus infection causes severe disease and a high rate of fatality in humans. Development of humanized monoclonal antibodies may provide an efficient therapeutic regime for H5N1 virus infection. In the present study, broadly cross-reactive monoclonal antibodies (MAbs) derived from mice were humanized to minimize immunogenicity. One chimeric antibody (cAb) and seven humanized antibodies (hAbs) were constructed. These antibodies retained broad-spectrum reactivity to H5N1 viruses, binding to recombinant H5-subtype HA1 molecules expressed in CHO cells in a dose-dependent manner and exhibiting similar reactivities against antigenically distinct H5N1 viruses in hemagglutination inhibition (HI) assays. One humanized antibody, 37 hAb, showed HI and neutralization activities comparable to that of the parental murine antibody, 13D4 MAb, while the other six antibodies were less reactive to H5N1 viruses. Analysis of amino acid sequences in the variable region frameworks of the seven humanized antibodies found that Q5 and Y27 in the VH region are highly conserved murine residues. Comparison of the three-dimensional structures derived from the variable regions of MAbs 37 hAb, H1202-34, and 13D4 revealed that residue substitutions at sites 70 and 46 may be the major cause for the observed differences in binding affinity. Examination of the chimeric antibody and one of the humanized antibodies, 37 hAb, showed that both antibodies offered postinfection protection against lethal challenge with antigenically diverse H5N1 viruses in the mouse model. Chimeric and humanized antibodies which retain the broadly reactive and protective properties of murine H5-specific monoclonal antibodies have great potential for use in the treatment of human H5N1 infection.
语种	英语
内容类型	期刊论文
源URL	[http://dspace.xmu.edu.cn/handle/2288/65591]
专题	生命科学－已发表论文
推荐引用方式 GB/T 7714	Zheng, Q. B.,Xia, L.,Wu, W. L.,et al. Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses[J]. http://dx.doi.org/10.1128/AAC.01436-10,2011.
APA	Zheng, Q. B..,Xia, L..,Wu, W. L..,Zheng, Z. H..,Huo, Y. T..,...&陈奕欣.(2011).Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses.http://dx.doi.org/10.1128/AAC.01436-10.
MLA	Zheng, Q. B.,et al."Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses".http://dx.doi.org/10.1128/AAC.01436-10 (2011).